Open AccessMedicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System
Author(s) -
Amanda J. Abraham,
Courtney R. Yarbrough,
Samantha J. Harris,
Grace Bagwell Adams,
Christina M. Andrews
Publication year - 2021
Publication title -
psychiatric services
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.517
H-Index - 145
eISSN - 1557-9700
pISSN - 1075-2730
DOI - 10.1176/appi.ps.202000049
Subject(s) - medicaid , opioid use disorder , specialty , buprenorphine , medicine , substance abuse , opioid , psychiatry , family medicine , health care , receptor , economics , economic growth
Research has examined the effect of Medicaid expansion on access to physicians with buprenorphine waivers, but less attention has been paid to Medicaid's impact on opioid use disorder medication availability within the specialty substance use disorder treatment system. To address this gap in the literature, this study examined the impact of Medicaid expansion on availability of opioid medications in specialty programs.